Trial Profile
Clinical Trials Insight: 700043604
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2009
Price :
$35
*
At a glance
- Drugs CB 182804 (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- Sponsors Cubist Pharmaceuticals
- 20 Apr 2009 New trial record.